Opsynvi

Business

J&J wins FDA nod for blood vessel disorder therapy, Opsynvi

hapabapa The U.S. Food and Drug Administration (FDA) has granted Johnson & Johnson (NYSE:JNJ) approval for its oral therapy combination,…

Read More »
Back to top button